EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modeling intestinal fibrosis in inflammatory bowel disease: translational animal models and ex vivo platforms

Rong Yan, Armand Ghozati, Haiming Chen, Kalyan Kumar Pasunooti, Waliul Islam, Ling Li, Florin M Selaru

Journal of Gastroenterology · 02.11.2026

DOI: 10.1007/s00535-026-02527-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology, online erschienen am 02.11.2026. Verfasst von Rong Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China. Die Arbeit nennt 105 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal fibrosis is a common and debilitating complication of inflammatory bowel disease (IBD), particularly Crohn's disease (CD). Fibrotic remodeling can also occur in ulcerative colitis (UC). Despite its clinical significance, there are currently no approved antifibrotic therapies, largely due to an incomplete understanding of the fibrogenic mechanisms and a lack of effective translational models. In this review, we examine several categories of animal models, including chemical-induced, microbial/biologic, immune cell-mediated, mechanical damage repair, genetically susceptible and cytokine-driven, and innovative models such as radiation-induced and organoid models. We evaluate the utility of these models in recapitulating key features of fibrotic IBD, including ECM remodeling, fibroblast activation, chronic inflammation, tissue stiffening, muscularis propria remodeling, and—in selected systems—fixed luminal narrowing/stricture. By outlining the advantages and limitations of each model, we aim to provide researchers with a practical, application-oriented framework that links each model to its optimal research use, thereby supporting the development of targeted, pathophysiologically-driven therapeutic strategies for IBD-associated fibrosis and fibrostenosis.

Schlagwörter

Stichwörter der Autor:innen

Animal modelCrohn’s diseaseFibrosisFibrostenosisIBDStricture

Autor:innen und Institutionen

  • First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China.
  • Division of Gastroenterology and Hepatology, School of Medicine, The Johns Hopkins University, Baltimore, MD, 21231, USA.
  • The College of Behavioral and Social Sciences (BSOS) at the University of Maryland, Baltimore, MD, 21231, USA.
  • Division of Gastroenterology and Hepatology, School of Medicine, The Johns Hopkins University, Baltimore, MD, 21231, USA. fselaru1@jhmi.edu.
  • Department of Oncology, Sidney Kimmel Cancer Center, The Johns Hopkins University, Baltimore, MD, 21231, USA. fselaru1@jhmi.edu.
  • The Institute for Nanobiotechnology, The Johns Hopkins University, 720 Rutland Ave, Suite 925, Baltimore, MD, 21231, USA. fselaru1@jhmi.edu.

Zitieren

APA

Yan, R., Ghozati, A., Chen, H., Pasunooti, K. K., Islam, W., Li, L., & Selaru, F. M. (2026). Modeling intestinal fibrosis in inflammatory bowel disease: translational animal models and ex vivo platforms. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02527-w

Vancouver

Yan R, Ghozati A, Chen H, Pasunooti KK, Islam W, Li L, et al. Modeling intestinal fibrosis in inflammatory bowel disease: translational animal models and ex vivo platforms. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02527-w

BibTeX
@article{Yan2026,
  author = {Yan, Rong and Ghozati, Armand and Chen, Haiming and Pasunooti, Kalyan Kumar and Islam, Waliul and Li, Ling and Selaru, Florin M},
  title = {Modeling intestinal fibrosis in inflammatory bowel disease: translational animal models and ex vivo platforms},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02527-w}
}
Kostenlos starten →